High Prevalence of Metabolic Syndrome in Patients with Discoid Lupus Erythematosus: A Cross-Sectional, Case-Control Study

Table 3

Comparison of clinical characteristics in DLE patients with and without metabolic syndrome.

Characteristics, (%)	DLE patients with MetS; ()	DLE patients without MetS; ()	value
Disease duration (month), mean ± SD			0.210
Use of antimalarials	8 (27.6%)	9 (29)	0.901
Location of DLE lesions, (%)
Face	25 (86.2)	27 (87.1)	1.00
Scalp	12 (41.4)	11 (35.5)	0.639
Trunk	9 (31)	8 (25.8)	0.653
Upper extremity	8 (27.6)	9 (29)	0.901
Lower extremity	2 (6.9)	2 (6.5)	1.00
Distribution of DLE lesions, (%)
Localized	18 (62.1)	21 (67.7)	0.645
Generalized	11 (37.9)	10 (32.3)	0.645
CLASI scores, mean ± SD
Total CLASI activity score			0.588
Erythema			0.346
Squama			0.939
Mucosal involvement			0.860
Noncicatricial alopecia			0.777
Total CLASI damage score			0.292
Dyspigmentation			0.145
Scarring			0.562
Cicatricial alopecia			0.430